文献速递泌尿生殖与妇科肿瘤放疗

前列腺癌患者对国际前列腺症状评分问卷理解程度的评估

Assessment of Patients With Prostate Cancer and Their Understanding of the International Prostate Symptom Score Questionnaire.
PubMed 文献 · Adv Radiat Oncol · 2023-02-23

本研究纳入144例连续前列腺癌患者,在放疗门诊就诊前1周内自行完成在线IPSS问卷,就诊时由护士逐题复核并核实答案。结果显示仅49%患者各题回答完全一致,护士核实后42%患者IPSS降低、6%升高,10%患者治疗选择资格发生变化。作者认为患者常误解IPSS问卷,临床医生应核实患者对问题的理解。

要点

  • 144例前列腺癌患者中仅70例(49%)护士核实前后各题回答完全一致。
  • 护士核实后61例(42%)IPSS降低、9例(6%)升高,患者核实前高估尿频、间歇性排尿和排空不全症状。
  • 护士核实使7例严重范围(20-35)患者中4例重归中度范围(8-19),10%患者治疗选择资格改变。

核心结论

  • 患者常误解IPSS问卷,导致回答不能准确反映其症状。
  • 临床医生应核实患者对IPSS问题的理解,尤其在用该评分决定治疗资格时。

研究设计与样本

  • 连续纳入144例前列腺癌患者,在放疗肿瘤门诊就诊前1周内自行完成在线IPSS问卷,就诊时由护士逐题复核并核实答案,记录并分析核实前与护士核实后评分的差异。

主要发现

  • 70例(49%)患者各IPSS问题核实前后回答完全一致。
  • 护士核实后61例(42%)IPSS降低或改善,9例(6%)IPSS升高或恶化。
  • 核实前患者高估尿频、间歇性排尿和排空不全症状。
  • 护士核实使7例严重范围(20-35)患者中4例重归中度范围(8-19)。
  • 核实前IPSS处于中度范围的患者中16%经护士核实后重归轻度范围(0-7),10%患者治疗选择资格发生变化。

关键数值与推荐

  • IPSS严重范围定义为20-35分,中度范围定义为8-19分,轻度范围定义为0-7分。

临床怎么用

  • 作者认为临床医生应核实患者对IPSS问题的理解,尤其在用该评分决定治疗资格时。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The International Prostate Symptom Score (IPSS) is a widely used tool for evaluating patient-reported lower urinary tract symptoms. In this study, we assessed patients with prostate cancer and their understanding of IPSS questions. METHODS AND MATERIALS: Consecutive patients with prostate cancer (N = 144) self-completed an online IPSS questionnaire within 1 week before their visit at our radiation oncology clinic. At the visit, a nurse reviewed each IPSS question to ensure the patient understood it and then verified the patient's answer. Preverified and nurse-verified scores were recorded and analyzed for discrepancies. RESULTS: Complete concordance between preverified and nurse-verified responses to individual IPSS questions existed for 70 men (49%). In terms of overall IPSS score, 61 men (42%) had a lower or improved IPSS after nurse verification, and 9 men (6%) had a higher or worse IPSS. Before verification, patients overstated their symptoms of frequency, intermittency, and incomplete emptying. As a result of the nurse verification, 4 of 7 patients with IPSS in the severe range (20-35) were recategorized to the moderate range (8-19). Sixteen percent of patients whose preverified IPSS were in the moderate range were recategorized after nurse verification to the mild range (0-7). Treatment option eligibility changed for 10% of patients after nurse verification. CONCLUSIONS: Patients frequently misunderstand the IPSS questionnaire, leading them to respond in ways that do not accurately reflect their symptoms. Clinicians should verify patient understanding of the IPSS questions, particularly when using the score to determine eligibility for treatments.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Gewanter RM, Sandhu JS, Tin AL, et al. Assessment of Patients With Prostate Cancer and Their Understanding of the International Prostate Symptom Score Questionnaire. Adv Radiat Oncol. 2023. PMID: 37213479. doi:10.1016/j.adro.2023.101200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。